Developing Molecular Surveillance Capacity for Asymptomatic and Drug-Resistant Malaria in a Resource-Limited Setting-Experiences and Lessons Learned. Academic Article uri icon

Overview

abstract

  • The COVID-19 pandemic has highlighted the important role molecular surveillance plays in public health. Such capacity however is either weak or nonexistent in many low-income countries. This article outlines a 2-year effort to establish two high-throughput molecular surveillance laboratories in Myanmar for tracking asymptomatic and drug resistant Plasmodium falciparum malaria. The lessons learned from this endeavor may prove useful for others seeking to establish similar molecular surveillance capacity in other resource-limited settings.

publication date

  • June 27, 2022

Research

keywords

  • Antimalarials
  • COVID-19
  • Malaria
  • Malaria, Falciparum

Identity

Digital Object Identifier (DOI)

  • 10.4269/ajtmh.21-0543

PubMed ID

  • 35895423